Publications:

Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer.

Molecular Oncology

Zhang, Lanxin L; Sun, Siwen S; Zhao, Xiaotian X; Liu, Jingwen J; Xu, Yang Y; Xu, Lingzhi L; Song, Chen C; Li, Na N; Yu, Jing J; Zhao, Shanshan S; Yu, Peiyao P; Fang, Fengqi F; Xie, Jiping J; Ji, Xuening X; Yu, Ruoying R; Ou, Qiuxiang Q; Zhao, Zuowei Z; Li, Man M

Publication Date: 2022-10

Variant appearance in text: EGFR: 2221C>A; P741T

PubMed Link: 35971249

Variant Present in the following documents:

• MOL2-16-3689-s005.xlsx, sheet 1

View BVdb publication page

Rational design of non-resistant targeted cancer therapies.

Scientific Reports

Martínez-Jiménez, Francisco F; Overington, John P JP; Al-Lazikani, Bissan B; Marti-Renom, Marc A MA

Publication Date: 2017-04-24

Variant appearance in text: EGFR: P741T

PubMed Link: 28436422

Variant Present in the following documents:

• Main text
• srep46632.pdf

View BVdb publication page

Novel heteroduplex method using small cytology specimens with a remarkably high success rate for analysing EGFR gene mutations with a significant correlation to gefitinib efficacy in non-small-cell lung cancer.

British Journal Of Cancer

Oshita, F F; Matsukuma, S S; Yoshihara, M M; Sakuma, Y Y; Ohgane, N N; Kameda, Y Y; Saito, H H; Yamada, K K; Tsuchiya, E E; Miyagi, Y Y

Publication Date: 2006-10-23

Variant appearance in text: EGFR: P741T

PubMed Link: 17047654

Variant Present in the following documents:

• Main text
• 95-6603396a.pdf

View BVdb publication page